Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026)
Edgewise Therapeutics' (EWTX) quarterly Amortizatization of Intangibles came in at $53000.0 in Q1 2026, down 97.24% year-on-year from $1.9 million in Q1 2025, and up 6.0% quarter-over-quarter from $50000.0 in Q4 2025.
Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Edgewise Therapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $53000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $53000.0, down 97.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 111.71% YoY), and the FY2025 annual result was $182000.0, down 98.55% from the prior year.
- Amortizatization of Intangibles came in at $53000.0 for Q1 2026 at Edgewise Therapeutics, up from $50000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $7.3 million in Q3 2023 to a low of -$4.0 million in Q3 2025.
- The 5-year median for Amortizatization of Intangibles is $1.4 million (2022), against an average of $1.3 million.
- Across the five-year window, Amortizatization of Intangibles slumped 358.37% in 2023 and surged 3598.08% in 2025, its largest moves.
- Edgewise Therapeutics' Amortizatization of Intangibles stood at $1.4 million in 2022, then soared by 57.16% to $2.2 million in 2023, then gained by 19.8% to $2.6 million in 2024, then tumbled by 98.08% to $50000.0 in 2025, then gained by 6.0% to $53000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $53000.0 (Q1 2026), $50000.0 (Q4 2025), and -$4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Edgewise Therapeutics | 3.52 Bn | 3.52 Bn | - | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,000.00 |
| Mar 31, 2026 | 53,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | -3.99 Mn |
| Sep 30, 2025 | -3.99 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Mar 31, 2024 | 52,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 2.17 Mn |
| Dec 31, 2023 | 2.17 Mn |